Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masha Fridkis-Hareli

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Autoimmune Diseases|February 16, 2008
Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseasesMasha Fridkis-Hareli
Clinical & Developmental Immunology|December 11, 2013
Design of peptide immunotherapies for MHC Class-II-associated autoimmune disordersMasha Fridkis-Hareli
Medical Immunology (London, England)|December 14, 2004
New approaches to eliciting protective immunity through T cell repertoire manipulation: the concept of thymic vaccinationMasha Fridkis-Hareli, Ellis L Reinherz
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Peptide variants of viral CTL epitopes mediate positive selection and emigration of Ag-specific thymocytes in vivoMasha Fridkis-Hareli, Pedro A Reche, Ellis L Reinherz
Cytokine|February 22, 2008
Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapyDerin B Keskin, Joel N H Stern, Masha Fridkis-Hareli, et al.
The Journal of Clinical Investigation|June 19, 2002
Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitisMasha Fridkis-Hareli, Laura Santambrogio, Joel N H Stern, et al.
Journal of Stem Cells|November 26, 2008
Stem Cells in Aging: Influence of Ontogenic, Genetic and Environmental FactorsEdmond J Yunis, Joaquin Zúñiga, Prasad S Koka, et al.
Blood|August 24, 2011
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseasesMasha Fridkis-Hareli, Michael Storek, Istvan Mazsaroff, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2005
Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitisJoel N H Stern, Zsolt Illés, Jayagopala Reddy, et al.
Human Immunology|December 6, 2006
Interaction of KIR genes and G1M immunoglobulin allotypes confer susceptibility to type 2 diabetes in Puerto Rican AmericansJoaquin Zuniga, Viviana Romero, Jose Azocar, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Autoimmune Diseases|February 16, 2008
Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseasesMasha Fridkis-Hareli
Clinical & Developmental Immunology|December 11, 2013
Design of peptide immunotherapies for MHC Class-II-associated autoimmune disordersMasha Fridkis-Hareli
Medical Immunology (London, England)|December 14, 2004
New approaches to eliciting protective immunity through T cell repertoire manipulation: the concept of thymic vaccinationMasha Fridkis-Hareli, Ellis L Reinherz
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Peptide variants of viral CTL epitopes mediate positive selection and emigration of Ag-specific thymocytes in vivoMasha Fridkis-Hareli, Pedro A Reche, Ellis L Reinherz
Cytokine|February 22, 2008
Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapyDerin B Keskin, Joel N H Stern, Masha Fridkis-Hareli, et al.
The Journal of Clinical Investigation|June 19, 2002
Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitisMasha Fridkis-Hareli, Laura Santambrogio, Joel N H Stern, et al.
Journal of Stem Cells|November 26, 2008
Stem Cells in Aging: Influence of Ontogenic, Genetic and Environmental FactorsEdmond J Yunis, Joaquin Zúñiga, Prasad S Koka, et al.
Blood|August 24, 2011
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseasesMasha Fridkis-Hareli, Michael Storek, Istvan Mazsaroff, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2005
Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitisJoel N H Stern, Zsolt Illés, Jayagopala Reddy, et al.
Human Immunology|December 6, 2006
Interaction of KIR genes and G1M immunoglobulin allotypes confer susceptibility to type 2 diabetes in Puerto Rican AmericansJoaquin Zuniga, Viviana Romero, Jose Azocar, et al.
Pageof 2